Patient Information:

• Name: Mr. Liu
• Diagnosis: Type II Diabetes Mellitus
• Date of Birth (D.O.B): August 1, 1966
• Gender: Male
• Country: China

Treatment: Cellular Immune Therapy for Type II Diabetes combined with Nerve Growth Factor Treatment, Physical Therapy, Traditional Chinese Medicine (TCM), and Metabolic Control Management at Kindgrove International Hospital (BPIH)

Medical History:
Mr. Liu was admitted to BPIH due to Type II Diabetes of ten years duration.

Medical Condition before Cellular Immune Therapy for Type II Diabetes:

• Symptoms:
  • Abnormal thirst
  • Nocturia
  • Intermittent blurred vision
• Medications:
  • Metformin
  • Phenformin
  • Insulin injections
• Laboratory Results:
  • HbA1c: 12.2%
  • Fasting Blood Glucose (FBG): 14.0 mmol/L (252 mg/dL)
  • Postprandial Blood Glucose (PBG): 23.6 mmol/L (425 mg/dL)

Cellular Immune Therapy for Type II Diabetes:

• Medical protocols applied:
  • Cellular immune therapy to repair injured pancreatic islet cells
  • Metabolic control management
  • Traditional Chinese medicine (TCM)
  • Rehabilitation therapy

Physical Condition after Cellular Immune Therapy for Type II Diabetes (30-day follow-up):

• Improved laboratory results:
  • HbA1c: 8.6%
  • FBG: 9.6 mmol/L (173 mg/dL) – a decrease of 4.4 mmol/L (79 mg/dL)
  • PBG: 14.2 mmol/L (256 mg/dL) – a decrease of 9.4 mmol/L (169 mg/dL)
• Insulin dosage reduced by 50%
• Improved sleep quality
• Significant alleviation of symptoms:
  • Thirst
  • Nocturia
  • Blurred vision